Association study between single nucleotide polymorphisms in the VEGF gene and polycystic ovary syndrome

Fertility and Sterility

Volumn 89, Issue 6, 2008, Pages 1751-1759

  Lee, Eung Ji ^a   Oh, Bermseok ^b   Lee, Jong Young ^b   Kimm, Kuchan ^b   Park, Jung Mi ^a   Baek, Kwang Hyun ^a  

^a CHA University   (South Korea)

^b Korea National Institute of Health   (South Korea)

Author keywords

polycystic ovary syndrome; single nucleotide polymorphism; vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; FEMALE; GENES, DOMINANT; GENOTYPE; HUMANS; KOREA; OBESITY; ODDS RATIO; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 44449124625     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.06.049     Document Type: Article

References (49)

1. Sheehan M.T. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res 2 (2004) 13-27
2. Byun E.K., Kim H.J., Oh J.Y., Hong Y.S., and Sung Y.A. The prevalence of polycystic ovary syndrome in college students from Seoul. J Kor Soc Endocrinol 20 (2005) 120-126
3. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long health risks related to polycystic ovary syndrome. Hum Reprod 19 (2004) 41-47
4. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
5. Escobar-Morreale H.F., Luque-Ramirez M., and San Millan J.L. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocrinol Rev 26 (2005) 251-282
6. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
7. Cascella T., Palomba S., Tauchmanova L., Manguso F., Di Biase S., Labella D., et al. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 91 (2006) 4395-4400
8. Legro R.S., Driscoll D., Strauss III J.F., Fox J., and Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95 (1998) 14956-14960
9. Goodarzi M.O., Antoine H.J., and Azziz R. Genes for enzymes regulating DHEA sulfonation are associated with levels of DHEA-sulfate in polycystic ovary syndrome. J Clin Endocrinol Metab 2 (2007) 2659-2664
10. Jones M.R., Wilson S.G., Mullin B.H., Mead R., Watts G.F., and Stuckey B.G. Polymorphism of the follistatin gene in polycystic ovary syndrome. Mol Hum Reprod 13 (2007) 237-241
11. Jones M.R., Italiano L., Wilson S.G., Mullin B.H., Mead R., Dudbridge F., et al. Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome. Fertil Steril 86 (2006) 1438-1446
12. Goodarzi M.O., Shah N.A., Antoine H.J., Pall M., Guo X., and Azziz R. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J Clin Endocrinol Metab 91 (2006) 4085-4091
13. Qin K., Ehrmann D.A., Cox N., Refetoff S., and Rosenfield R.L. Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J Clin Endocrinol Metab 91 (2006) 270-276
14. Seow K.M., Juan C.C., Hsu Y.P., Hwang J.L., Huang L.W., and Ho L.T. Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery. Hum Reprod 22 (2007) 1003-1010
15. Ehrmann D.A., Tang X., Yoshiuch I., Cox N.J., and Bell G.I. Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 4297-4300
16. Lee E.J., Yoo K.J., Kim S.J., Lee S.H., Cha K.Y., and Baek K.H. Single nucleotide polymorphism in exon 17 of insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population. Fertil Steril 86 (2006) 380-384
17. Antoine H.J., Pall M., Trader B.C., Chen Y.D., Azziz R., and Goodarzi M.O. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil Steril 87 (2007) 862-869
18. Vollmert C., Hahn S., Lamina C., Huth C., Kolz M., Schöpfer-Wendels A., et al. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am J Physiol Endocrinol Metab 292 (2007) E836-E844
19. González A., Sáez M.E., Aragón M.J., Galán J.J., Vettori P., Molina L., et al. Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome. Hum Reprod 21 (2006) 943-951
20. Heinonen S., Korhonen S., Helisalmi S., Koivunen R., Tapanainen J., Hippeläinen M., et al. Associations between two single nucleotide polymorphisms in the adiponectin gene and polycystic ovary syndrome. Gynecol Endocrinol 21 (2005) 165-169
21. Heinonen S., Korhonen S., Helisalmi S., Koivunen R., Tapanainen J.S., and Laakso M. The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome. Fertil Steril 82 (2004) 743-745
22. Lin T.C., Yen J.M., Gong K.B., Kuo T.C., Ku D.C., Liang S.F., et al. Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism. BMC Med Genet 7 (2006) 36
23. Fraser H.M. Regulation of the ovarian follicular vasculature. Reprod Biol Endocrinol 4 (2006) 18
24. Geva E., Jaffe R.B., and Edward W.E. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74 (2000) 429-438
25. Grasselli F., Tirelli M., Cavalli V., Bussolati S., and Tamanini C. VEGF, bFGF and swine granulosa cells: proliferation, steroidogenesis and NO production. Vet Res Commun 1 (2003) 233-235
26. Shimizu T. Promotion of ovarian follicular development by injecting vascular endothelial growth factor (VEGF) and growth differentiation factor 9 (GDF-9) genes. J Reprod Dev 52 (2006) 23-32
27. Artini P.G., Monti M., Matteucci C., Valentino V., Cristello F., and Genazzani A.R. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation. Gynecol Endocrinol 22 (2006) 465-470
28. Reynolds L.P., Grazul-bilska A.T., and Redmer D.A. Angiogenesis in the female reproductive organs: pathological implications. Int J Exper Pathol 83 (2002) 151-163
29. Kamat B.R., Brown L.F., Manseau E.J., Senger D.R., and Dvorak H.F. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 146 (1995) 157-165
30. Patel S.R., and Korytkowski M.T. Polycystic ovary syndrome: How best to establish the diagnosis. Womens Health Prim Care 3 (2000) 55-69
31. Ferrara N., Frantz G., LeCouter J., Dillard-Telm L., Pham T., Draksharapu A., et al. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol 162 (2003) 1881-1893
32. Kim J., Park J., Kim S., Choi Y., Shin C., Moon S., et al. Clinical study on infertile women with oligomenorrhea. Kor J Obstet Gynecol 38 (1995) 824-826
33. Carmina E., Rosato F., Janni A., Rizzo M., and Longo R.A. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91 (2006) 2-6
34. Jung H.Y., Park J.S., Park Y.J., Kim Y.J., Kimm K., and Kho I. HapAnalyzer: Minimum Haplotype Analysis System for Association Studies. Genomics Inform 2 (2004) 107-109
35. Kim Y., Nam Y.J., and Lee C. Haplotype analysis of single nucleotide polymorphisms in VEGF gene for vascular dementia. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 332-335
36. Banyasz I., Szabo S., Bokodi G., Vannay A., Vasarhelyi B., Szabo A., et al. Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Mol Hum Reprod 12 (2006) 233-236
37. Rueda B., Perez-Armengol C., Lopez-Lopez S., Garcia-Porrua C., Martin J., and Gonzalez-Gay M.A. Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schonlein purpura. J Rheumatol 33 (2006) 69-73
38. Vannay A., Vasarhelyi B., Kornyei M., Treszl A., Kozma G., Gyorffy B., et al. Single-nucleotide polymorphisms of VEGF gene are associated with risk of congenital valvuloseptal heart defects. Am Heart J 151 (2006) 878-881
39. Lambrechts D., Devriendt K., Driscoll D.A., Goldmuntz E., Gewillig M., Vlietinck R., et al. Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study. J Med Genet 42 (2005) 519-522
40. Jacobs E.J., Feigelson H.S., Bain E.B., Brady K.A., Rodriguez C., Stevens V.L., et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 8 (2006) R22
41. Ku K.T., Wan L., Peng H.C., Tsai M.H., Tsai C.H., and Tsai F.J. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol 41 (2005) 497-502
42. Berse B., Brown L.F., Van De Water L., Dvorak H.F., and Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3 (1992) 211-220
43. Chen K., and Rajewsky N. Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 38 (2006) 1452-1456
44. Clop A., Marcq F., Takeda H., Pirottin D., Tordoir X., Bibe B., et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38 (2006) 813-818
45. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102 (2005) 19075-19080
46. Ying S.Y., and Lin S.L. Current perspectives in intronic micro RNAs (miRNAs). J Biomed Sci 13 (2006) 5-15
47. Iwai N., and Naraba H. Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 331 (2005) 1439-1444
48. Ying S.Y., and Lin S.L. Intronic microRNAs. Biochem Biophys Res Commun 326 (2005) 515-520
49. Agrawal R., Jacobs H., Payne N., and Conway G. Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 78 (2002) 1164-1169